San Diego Business Journal

from June 24, 1985
Last Document: March 26, 2012

ISSN 8750-6890

RSS What's this?

Browse by Day

Index

Sections

News
Interview
Feature

Calendar

2004August

September July

Other related sources

San Diego Business Journal

San Diego Business Journal, August 09, 2004

Del Mar Thoroughbred Club plans to bring more audience

Ponies make pitch to younger fans: horse racing just part of Del Mar track's appeal.

Employers send message on e-mail: legislators addressing electronic monitoring.

Radio stations wage good ol' country brawl: new US 95.7, established KSON battle for top spot.

ProjectDesign Consultants focus on unincorporated areas - Industry Overview

Demand increases for real estate advisers.

Construction

Barratt American buys assets from parent firm: builder will keep Carlsbad headquarters, project and land inventory.

Failed deal puts Titan down $66m in 2nd quarter.

Tourism

Room to negotiate possible in hotel-tax measure: council opts to put tax hike before city voters in November.

San Diego Convention & Visitors Bureau - Transient occupancy tax

ConVis: long-term effects of TOT hike ignored.

Retail - Brief Article

Thank heaven for 7-Elevens throughout Downtown S.D.: El Cajon City Council to assess $511 fee for license to sell tobacco.

Retail - El Cajon City Council - Brief Article

Tobacco license update.

Retail - Brief Article

Buying in bulk.

Retail - Brief Article

Final tally.

Retail - Brief Article

One and only.

Retail - Brief Article

Cheap window coverings.

Brief Article

Gaslamp quarter members can get deals.

Law

Attorneys say workplace issues among biggest fears: former Roel exec joins construction law firm Perkins & Miltner, LLP.

Law - Brief Article

Partnering up.

Marketing

Firms deal with the politics of governmental P.R.: clear channel inks pact to put ads on buses.

Technology

Websense evolves along with internet: proactive approach to locating viruses appeals to many large companies.

Biotech - Brief Article

Sequenom's struggles lead to layoffs: trial success of company's lupus drug produces delight among investors.